Literature DB >> 19874877

Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses.

George Mattheolabakis1, George Lagoumintzis, Zoi Panagi, Evangelia Papadimitriou, Charalambos D Partidos, Konstantinos Avgoustakis.   

Abstract

We investigated the influence of antigen entrapment in PLA nanoparticles on the immune responses obtained after transcutaneous immunization. OVA-loaded PLA nanoparticles were prepared using a double emulsion process. Following application onto bare skin of mice in vivo, fluorescence-labeled nanoparticles were detected in the duct of the hair follicles indicating that the nanoparticles can penetrate the skin barrier through the hair follicles. Although the OVA-loaded nanoparticles elicited lower antibody responses than those induced by OVA in aqueous solution they were more efficient in inducing cytokine responses. In vitro re-stimulation of cultured splenocytes with OVA elicited a little higher levels of IFN-gamma (difference statistically insignificant, p>0.05) and significantly higher levels of IL-2 (p<0.001) in mice immunized with OVA-loaded nanoparticles compared to those immunized with OVA in solution. In the presence of CT, the OVA-loaded nanoparticles induced significantly higher IFN-gamma and IL-2 than all other formulations. Transcutaneous administration of OVA encapsulated in the PLA nanoparticles exhibited priming efficacy to a challenging dose of OVA given via different route. These findings indicate the potential of nanoparticles to deliver antigens via the transcutaneous route and prime for antibody and strong cellular responses. The co-administration of an adjuvant such as CT had the added advantage of modulating the immune response, a desirable characteristic within the context of vaccination against intracellular versus extracellular pathogens. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874877     DOI: 10.1016/j.ijpharm.2009.10.033

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  Convergence of nanotechnology and cancer prevention: are we there yet?

Authors:  David G Menter; Sherri L Patterson; Craig D Logsdon; Scott Kopetz; Anil K Sood; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-24

2.  Topically applied phospho-sulindac hydrogel is efficacious and safe in the treatment of experimental arthritis in rats.

Authors:  George Mattheolabakis; Gerardo G Mackenzie; Liqun Huang; Nengtai Ouyang; Ka Wing Cheng; Basil Rigas
Journal:  Pharm Res       Date:  2013-03-13       Impact factor: 4.200

Review 3.  Nanoparticle delivery systems in cancer vaccines.

Authors:  Yogita Krishnamachari; Sean M Geary; Caitlin D Lemke; Aliasger K Salem
Journal:  Pharm Res       Date:  2010-08-19       Impact factor: 4.580

Review 4.  Nanoparticles for transcutaneous vaccination.

Authors:  Steffi Hansen; Claus-Michael Lehr
Journal:  Microb Biotechnol       Date:  2011-08-19       Impact factor: 5.813

Review 5.  Microbes in Tumoral In Situ Tissues and in Tumorigenesis.

Authors:  Xue Feng; Lu Han; Sijia Ma; Lanbo Zhao; Lei Wang; Kailu Zhang; Panyue Yin; Lin Guo; Wei Jing; Qiling Li
Journal:  Front Cell Infect Microbiol       Date:  2020-11-24       Impact factor: 5.293

Review 6.  Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.

Authors:  Kazuhiko Matsuo; Sachiko Hirobe; Naoki Okada; Shinsaku Nakagawa
Journal:  Vaccine       Date:  2013-03-21       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.